3.2 Contrast-Induced Nephropathy & Adverse Reaction Management
Key Takeaways
CA-AKI identifies a temporal relationship. CI-AKI requires evidence that contrast caused the injury. Apply the published KDIGO creatinine or urine output criteria for AKI.
Cardiac catheterization contrast-volume rules are risk estimates from specific cohorts. Track cumulative volume and use a patient- and procedure-specific plan.
For selected high-risk patients receiving IV iodinated contrast, consider isotonic saline when clinically appropriate and weigh fluid overload risk. The arterial procedure plan can involve additional risk factors.
ACR advice about continuing metformin at eGFR at least 30 without AKI applies to IV iodinated contrast. Arterial studies with renal embolic risk and FDA product labeling require separate checks.
Recognize anaphylaxis and prepare prompt epinephrine under the clinical protocol. Use the symptoms and vital sign trends together to distinguish severe allergic-like reactions from a vasovagal episode.
3.2 Contrast-Induced Nephropathy & Adverse Reaction Management
Clinical Core: An acute rise in creatinine after contrast establishes timing and prompts evaluation for the cause. Check kidney function, exposure route and fluid status before the procedure. For an acute contrast reaction, assess the symptom pattern, trend vital signs and recognize when airway or circulatory compromise requires immediate escalation.
Contrast-Associated and Contrast-Induced Acute Kidney Injury
Contrast-associated AKI (CA-AKI) describes an acute decline in renal function within 48 hours after intravascular iodinated contrast. Contrast-induced AKI (CI-AKI) refers to injury attributable to the contrast itself. Older sources often use contrast-induced nephropathy (CIN). A creatinine rise establishes the timing. The clinical assessment also considers concurrent hypotension, arterial atheroembolism, infection and nephrotoxic exposures. Changes in renal blood flow and direct tubular effects are proposed mechanisms of CI-AKI.
Recognizing Acute Kidney Injury
The published KDIGO definition identifies AKI when at least one of these criteria is met:
- Serum creatinine increases by at least 0.3 mg/dL within 48 hours.
- Serum creatinine rises to at least 1.5 times baseline, known or presumed to have occurred within the prior 7 days.
- Urine output falls below 0.5 mL/kg/h for 6 hours.
Worked interpretation. Creatinine rises from 1.20 to 1.53 mg/dL 36 hours after angiography. The increase is 0.33 mg/dL and meets the first KDIGO criterion even though the relative rise is below 50%. The onset follows contrast within 48 hours. It can be described as CA-AKI while the care team assesses the cause. An episode of sustained hypotension during the procedure would be relevant to that assessment.
Identifying Patients Who Need a Risk Review
Review pre-existing kidney disease, eGFR, creatinine trend, hemodynamics and route of contrast delivery. Active AKI and advanced CKD merit particular attention. Concurrent volume depletion or heart failure may also affect the procedural plan. Keep IV CT risk estimates in their original setting. With arterial catheter procedures, arterial manipulation, embolization and hemodynamic changes can add to risk. Discuss contrast-sparing imaging and procedure urgency with the operator.
Contrast Dosing Limits and Nephropathy Prevention Strategies
Contrast Volume and Exposure
During arterial interventions, track cumulative contrast and alert the operator as the planned exposure is approached. Interpret numerical risk tools in their original studies. Cigarroa's 1989 cardiac catheterization study used a historical rule based on five times body weight in kilograms divided by creatinine in mg/dL, with a 300 mL upper cap described in the study. For a 60 kg patient with creatinine 2.0 mg/dL, the estimate is . This estimate comes from a cardiac catheterization cohort. In a later PCI cohort, Laskey and colleagues found that a contrast-volume-to-creatinine-clearance ratio of at least 3.7 was associated with early creatinine rise. The study used estimated creatinine clearance. These are risk tools from particular cohorts. Contemporary procedural planning uses the patient's risks, clinical need and available imaging and device options.
Preventive Fluid Planning
For intravenous contrast, ACR/NKF recommends prophylactic IV isotonic saline for patients with AKI or eGFR below 30 mL/min/1.73 m² who are not on maintenance dialysis, unless fluid expansion poses a contraindication. In selected high-risk circumstances the team may consider prophylaxis at eGFR 30–44. Fluid volume and timing must account for congestion or heart failure and the clinical context. A team planning an arterial intervention assesses contrast exposure and procedural risks for that case. A needed diagnostic study should remain diagnostic and a time-sensitive intervention needs an urgency-specific plan.
In PRESERVE, a randomized trial in CKD patients undergoing angiography, IV sodium bicarbonate had no demonstrated advantage over saline, and oral N-acetylcysteine had no demonstrated advantage over placebo for the study outcomes, including CA-AKI.
Metformin and the Route of Contrast Administration
Metformin can accumulate if acute kidney function worsens. Accumulation can contribute to lactic acidosis. Check the route as well as the creatinine trend before applying the ACR categories.
| Situation | ACR contrast-manual guidance |
|---|---|
| IV iodinated contrast, eGFR at least 30 and no AKI | Metformin may continue. Routine renal retesting solely for metformin is unnecessary. |
| AKI, eGFR below 30, or an arterial catheter study that can send emboli to the renal arteries | Hold metformin at or before the procedure and for 48 hours afterward. Re-evaluate kidney function before restart. |
U.S. labeling for individual metformin products can use broader criteria. For example, the 2026 Fortamet label directs holding metformin for eGFR 30–60, a history of hepatic impairment, alcoholism or heart failure, or intra-arterial iodinated contrast. That label calls for eGFR reassessment at 48 hours and restart if renal function is stable. Verify the exposure route, product, local policy and clinician's orders. A preserved eGFR does not answer the arterial-catheter question by itself.
Adverse Contrast Reactions: ACR Classification & Emergency Management
Classifying the Pattern and Severity
Acute reactions to iodinated contrast can be allergic-like or physiologic. Some allergic-like reactions involve IgE and others involve different mechanisms. The clinical picture determines initial recognition and escalation.
| Severity | Allergic-like example | Physiologic example |
|---|---|---|
| Mild | Limited hives or itching | Transient warmth or limited nausea |
| Moderate | Diffuse hives, or bronchospasm with little or no hypoxia | Protracted nausea and vomiting, or a vasovagal episode responding to treatment |
| Severe | Stridor, significant hypoxia, or anaphylactic circulatory compromise | A vasovagal episode resistant to treatment, arrhythmia or seizure |
Stop the contrast injection if a reaction occurs. Maintain IV access, assess airway, breathing and circulation, check vital signs and call the appropriate team. Mild symptoms still require observation for progression. The team can select symptom-directed treatments for skin symptoms or isolated bronchospasm when appropriate. Record the agent, timing, symptoms, treatment and response.
Anaphylaxis and Vasovagal Events
New stridor, respiratory compromise, widespread hives or circulatory compromise after contrast can signal anaphylaxis. A vasovagal episode often presents with pallor, diaphoresis, hypotension and a slow pulse. Use the whole pattern. Heart rate alone cannot establish or exclude anaphylaxis.
For suspected anaphylaxis, activate the response and prepare epinephrine promptly. The September 2026 ACR adult contrast reaction card lists 0.3 mg IM as 0.3 mL of 1 mg/mL with the IM option for severe airway involvement or reaction-related hypotension. Inject into the anterolateral thigh under the applicable protocol. The ACR card also gives a distinct IV dose and dilution for trained clinicians in a monitored setting. Doses and concentrations for the two routes are different. Oxygen, airway support, IV fluid for shock and further care are coordinated by the response team. Antihistamines and corticosteroids cannot replace epinephrine for acute airway or circulatory compromise. Observe for persistent or recurrent symptoms under the clinical plan.
In a suspected vasovagal episode with hypotension and a slow pulse, prepare supportive measures, monitor continuously and escalate if hypotension persists. The adult ACR contrast card includes leg elevation when appropriate, IV saline and atropine for refractory symptoms. The separate AHA 2025 adult bradycardia-with-a-pulse algorithm gives an initial IV atropine dose of 1 mg for persistent bradycardia with cardiopulmonary compromise. Use the protocol for the clinical setting. High or low heart rate can have other causes, including hemorrhage or medication effects.
Premedication Protocols for Documented Prior Contrast Allergy
For deciding whether premedication is indicated, apply the 2025 ACR/AAAAI consensus on prior iodinated contrast hypersensitivity. It advises agent substitution when feasible after a mild or moderate immediate reaction, premedication consideration after a moderate reaction and evaluation of alternative imaging first after a severe reaction. If there is no acceptable alternative after a severe immediate reaction, plan agent substitution when possible, premedication and a hospital response team. A shellfish allergy by itself does not call for a change in agent or premedication.
When premedication is chosen, the ACR contrast manual provides example regimens with different lead times. An elective oral example is prednisone 50 mg at 13, 7 and 1 hours before contrast. The oral protocol may include an antihistamine. For the accelerated IV approach, the example steroid regimen in the manual generally takes 4–5 hours. Regimens shorter than that have no established efficacy. A clinician determines whether delay is appropriate for the procedure. Premedication can still be followed by a breakthrough reaction, so readiness for emergency treatment remains essential.
Serum creatinine increases from 1.40 to 1.72 mg/dL 30 hours after peripheral angiography. The patient also had sustained procedural hypotension. Which interpretation is best supported?
The creatinine does not meet any AKI criterion because its increase is less than 50%
Contrast definitively caused the injury because creatinine rose within 48 hours
The creatinine establishes permanent kidney injury because the new value exceeds 1.5 mg/dL
The increase meets a KDIGO AKI criterion and supports the temporal term CA-AKI. The contribution of contrast, hypotension and other causes needs clinical assessment
A patient taking metformin has stable eGFR 62 mL/min/1.73 m² and no AKI. The clinician plans a renal artery catheter study that may dislodge plaque into the renal circulation. Which ACR metformin category applies?
Continue metformin and omit renal re-evaluation based only on eGFR above 30
Hold metformin at or before the study and for 48 hours afterward, and reassess kidney function before restarting
Stop metformin 48 hours before any contrast study and resume immediately after the procedure
Discontinue metformin permanently because renal artery catheterization always reduces filtration
An adult develops diffuse hives and inspiratory stridor minutes after iodinated contrast. The emergency response has been activated. Under the ACR adult card, which preparation matches the initial IM treatment option?
Atropine 1 mg IV to address stridor
Diphenhydramine alone as primary treatment for airway compromise
Epinephrine 0.3 mL of the 1 mg/mL concentration IM, for a dose of 0.3 mg
Epinephrine 0.3 mL of the 0.1 mg/mL concentration IM, for a dose of 0.3 mg
Sections you finish are checked off in the contents.